Clinical Trials Logo

Diffuse Diabetic Macular Edema clinical trials

View clinical trials related to Diffuse Diabetic Macular Edema.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01218750 Recruiting - Clinical trials for Diffuse Diabetic Macular Edema

Triple Therapy for Diffuse Diabetic Macular Edema

TTDDME
Start date: December 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety end efficacy of combined phakoemulsification and vitrectomy with retinal endophotocoagulation and intraoperative use of bevacizumab in patients with diffuse diabetic macular edema (DDME), to determine the possible preoperative and intraoperative factors that might influence surgical outcomes.

NCT ID: NCT00999791 Recruiting - Clinical trials for Diffuse Diabetic Macular Edema

Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema

Start date: July 2009
Phase: Phase 1
Study type: Interventional

Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.